4-Amino-3-Chlorophenol CAS 17609-80-2 Lenvatinib Mesylate Intermediate Purity >99.0% (HPLC)

Fa'amatalaga Puupuu:

Igoa Vailaau: 4-Amino-3-Chlorophenol

CAS: 17609-80-2

Mama: >99.0% (HPLC)

Fa'aaliga: Enaena Uila Malosi

Intermediate o Lenvatinib Mesylate CAS 857890-39-2

Fa'afeso'ota'i: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Fa'amatalaga Oloa

Oloa Fa'atatau

Faailoga o oloa

Fa'amatalaga:

Meatotino tau vailaau:

Igoa Vailaau 4-Amino-3-Chlorophenol
Synonyms 3-Chloro-4-Aminophenol;Lenvaint-G
Numera CAS 17609-80-2
CAT Numera RF-PI1968
Tulaga Fa'asoa I Fa'atauga, Oloa Fua e O'o i Tone
Fuafua mole C6H6ClNO
Molecular Weight 143.57
Malosi 1.406±0.060g/cm3
Fa'ailoga Ruifu Chemical

Fa'amatalaga:

Aitema Fa'amatalaga
Fa'aaliga Enaena Uuta Malosi
1 H NMR Alaleo Osi ma le Fauga
Fa'ailoa-HPLC Ole taimi fa'atumauina e tutusa ma tulaga masani
Mama / Suʻesuʻega Metotia >99.0% (HPLC)
Lisi Lisi 138.0~141.0 ℃
Ma'imau ile Fa'amago <1.00%
Toega i luga o le mumu <0.30%
Aofa'i Fa'aleaga <1.00%
Tulaga Su'ega Pisinisi Tulaga
Fa'aoga Intermediate o Lenvatinib Mesylate (CAS: 857890-39-2)

Paket & Teuina:

afifi: Fagu, ato pepa alumini, 25kg/Kati Pusa, pe tusa ai ma manaoga o tagata faatau

Tulaga teuina:Teu i totonu o pusa faʻamaufaʻailoga i se nofoaga malulu ma mago;Puipui mai le malamalama ma le susu

Tulaga lelei:

1

FAQ:

Talosaga:

4-Amino-3-Chlorophenol (CAS: 17609-80-2) o se vailaʻau taua tele, lea e faʻaaogaina lautele i le mamanu ma le tuʻufaʻatasia o anti-tumor, maʻi cardiovascular, faʻamaʻi faʻamaʻi faʻamaʻi.4-Amino-3-Chlorophenol o se mea taua tele i le sauniuniga o le Lenvatinib Mesylate (CAS: 857890-39-2).Na atiaʻe e Eisai Inc., lenvatinib mesylate o se vascular endothelial growth factor receptor (VEGF) inhibitor o loʻo i ai le gaioiga e faasaga i le VEGF subtypes 1, 2, ma le 3 ma na faʻatagaina e le FDA i le 2015 mo le togafitiga o le kanesa thyroid eseese lea e faʻapitonuʻu. faifai pea, metastatic, poʻo le alualu i luma ma e leʻi tali atu i togafitiga iodine radioactive.I le masina o Me 2016, na faʻamaonia ai e le FDA le vailaʻau e avea o se togafitiga faʻatasi ma everolimus mo le togafitiga o le gasegase o le tino.Talu ai ona o le VEGF (ma le fibroblast growth factor receptors, ua taʻua o FGFRs) e manatu e faia se sao i ala cardiovascular signaling, o le VEGF2R ma le FGFR inhibition o loʻo manatu o auala ia i tua atu o aʻafiaga muamua o le lenvatinib mesylate, o le toto maualuga.

Tusi lau savali iinei ma lafo mai ia i matou